Pfizer beats profit estimates on cost cuts, COVID vaccine sales
(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine. "Our revenue volatility is largely in the past as COVID-related uncertainties have diminished,
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's nomination moved forward.
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.”  | The company benefited from higher-than-expected sales of COVID vaccine Comirnaty and antiviral Paxlovid,
Pfizer Beats Profit Estimates on Heart Disease Drug, COVID Vaccine Sales
(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of its heart disease drug and a smaller-than-feared drop in COVID vaccine sales.
Pfizer gets unexpected boost from Covid vaccine and pill
Sales of the Covid vaccine and pill were around $550 million more than analysts had been expecting for the quarter. Pfizer investors are trying to figure out what the “new normal” will be for those products as interest in treating the virus fades with time.
KMOV St. Louis on MSN3h
Nasal COVID vaccine developed at WashU approved for clinical trials
The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
Michigan flu, RSV, COVID surges wreak 'havoc' in Corewell emergency departments
Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...
Trump's reinstatement of troops booted over COVID vaccine hailed as win for freedom: 'Great day for patriots'
Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...
CNN on MSN13d
NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandates
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
Time on MSN7d
RFK Jr. Says He Doesn’t Know if COVID-19 Vaccines Work
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
EurekAlert!2d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
thecardiologyadvisor.com3d
COVID-19 Vaccine Confers Protection Against Post-COVID-19 Conditions
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
infectiousdiseaseadvisor.com8d
COVID-19 Vaccine: ACIP Recommends Added Doses in All With IC and Adults 65+
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.
McKnight's Long-Term Care News13h
‘Vaccine fatigue’ could be a common LTC theme in 2025
Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.